Emerging Options for Cancer Treatment (Part 2)
Acute myeloid leukemia (AML) is the most common type of blood cancer. Unlike other cancers, there is no way screening prevention or some other way to prevent AML. When diagnosed with AML, cancer affects the entire body beginning with one’s bone marrow and blood cells, so the goal of treatment is mostly to cure the cancer.
In this second part of Emerging Options for Cancer Treatment, Dr. Sara Park, Malignant Hematologist with Dignity Health St. Joseph’s Hospital and Medical Center, will share a brief recap of complex field of cellular therapies and discuss the many treatment options for patients diagnosed with AML, including chemotherapy and cutting-edge stem cell therapy.
Session participants will learn about:
• Recap of cellular therapies
• The behavior of blood cancers or acute myeloid leukemias
• Basic treatment sequence of acute myeloid leukemias
• Novel blood cancer treatments
About our speaker:
Soyoung “Sara” Park, MD
The University of Arizona Cancer Center at Dignity Health St. Joseph’s Hospital and Medical Center
Dr. Park’s expertise includes acute and chronic leukemias, lymphomas, acquired bone marrow disorders, multiple myeloma, and myeloproliferative neoplasms and she is board certified in internal medicine, hematology and oncology. She is a member of American Society of Hematology, American Society of Clinical Oncology, and American College of Physicians.
Dr. Park received her degree from Tulane University School of Medicine and she completed her residency training in internal medicine at University of Arizona and a fellowship in hematology-oncology at University of Arizona Cancer Center/Banner University Medical Center in Tucson, AZ.
Dr. Park believes in treating not just the patient’s cancer but the individual person as well. Throughout her training, she realized that the emotional aspect of one’s therapy is just as crucial as the medical component. The many different patients she has cared for previously have consistently inspired her to become a more compassionate physician.
For more information, contact Teresa Salama at: